Evidence map›Paper›PMID 41479008›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Methods and Guidelines for Analyzing the Conformational Dynamics of Proteins in the Antigen Presentation Pathway.

Athanasios Papakyriakou

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Athanasios PapakyriakouInstitute of Biosciences and Applications, National Centre for Scientific Research Demokritos, Agia Paraskevi, Greece. thpap@bio.demokritos.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endoplasmic reticulum aminopeptidase 1 (ERAP1) digests antigenic precursors up to the optimum length for binding to the major histocompatibility complex (MHC) class I. This zinc-dependent aminopeptidase has been found in a catalytically active closed conformation and in open conformations that expose its substrate-binding cavity to the bulk solvent. Therefore, its activity has been linked to catalytic cycles between conformational states that accommodate substrate binding, peptide hydrolysis and product release. During the last decade, X-ray crystallography in conjunction with biophysical and enzymatic studies has deciphered the remarkable peptide-length dependence of ERAP1, the allosteric regulation mechanism, and the role of disease-associated polymorphisms. In this regard, molecular dynamics (MD) simulations have contributed to atomic-level investigations of ERAP1 conformational dynamics. This chapter provides a detailed protocol to generate the systems required to carry out and analyze atomistic MD simulations of ERAP1 with a bound inhibitor in explicit solvent, starting from different conformational states. This protocol is also applicable to the analysis of the conformational dynamics of other aminopeptidases in the antigen presentation pathway.

Indexed as

AminopeptidasesAntigen PresentationMinor Histocompatibility AntigensMolecular Dynamics SimulationCrystallography, X-RayHistocompatibility Antigens Class IHumansProtein BindingProtein ConformationAminopeptidasesERAP1 protein, humanHistocompatibility Antigens Class IMinor Histocompatibility AntigensAllosteric regulationAllotypeConformational dynamicsERAP1ERAP2IRAPM1 aminopeptidaseMolecular Dynamics (MD) simulationsOpen–closed stateZinc-dependent enzyme

Identifiers

PMID41479008

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.